133 related articles for article (PubMed ID: 10728678)
1. CD95 (Fas/APO-1) and p53 signal apoptosis independently in diverse cell types.
O'Connor L; Harris AW; Strasser A
Cancer Res; 2000 Mar; 60(5):1217-20. PubMed ID: 10728678
[TBL] [Abstract][Full Text] [Related]
2. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation.
Amanullah A; Liebermann DA; Hoffman B
Oncogene; 2002 Feb; 21(10):1600-10. PubMed ID: 11896589
[TBL] [Abstract][Full Text] [Related]
3. Altered trafficking of Fas and subsequent resistance to Fas-mediated apoptosis occurs by a wild-type p53 independent mechanism in esophageal adenocarcinoma.
Mahidhara RS; Queiroz De Oliveira PE; Kohout J; Beer DG; Lin J; Watkins SC; Robbins PD; Hughes SJ
J Surg Res; 2005 Feb; 123(2):302-11. PubMed ID: 15680394
[TBL] [Abstract][Full Text] [Related]
4. Involvement of p53 and Fas/CD95 in murine neural progenitor cell response to ionizing irradiation.
Semont A; Nowak EB; Silva Lages C; Mathieu C; Mouthon MA; May E; Allemand I; Millet P; Boussin FD
Oncogene; 2004 Nov; 23(52):8497-508. PubMed ID: 15361846
[TBL] [Abstract][Full Text] [Related]
5. Murine male germ cell apoptosis induced by busulfan treatment correlates with loss of c-kit-expression in a Fas/FasL- and p53-independent manner.
Choi YJ; Ok DW; Kwon DN; Chung JI; Kim HC; Yeo SM; Kim T; Seo HG; Kim JH
FEBS Lett; 2004 Sep; 575(1-3):41-51. PubMed ID: 15388331
[TBL] [Abstract][Full Text] [Related]
6. Role of p53 in regulating constitutive and X-radiation-inducible CD95 expression and function in carcinoma cells.
Sheard MA; Uldrijan S; Vojtesek B
Cancer Res; 2003 Nov; 63(21):7176-84. PubMed ID: 14612511
[TBL] [Abstract][Full Text] [Related]
7. Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants.
Zalcenstein A; Stambolsky P; Weisz L; Müller M; Wallach D; Goncharov TM; Krammer PH; Rotter V; Oren M
Oncogene; 2003 Aug; 22(36):5667-76. PubMed ID: 12944915
[TBL] [Abstract][Full Text] [Related]
8. p53 promotes selection for Fas-mediated apoptotic resistance.
Maecker HL; Koumenis C; Giaccia AJ
Cancer Res; 2000 Aug; 60(16):4638-44. PubMed ID: 10969818
[TBL] [Abstract][Full Text] [Related]
9. The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites.
Longley DB; Allen WL; McDermott U; Wilson TR; Latif T; Boyer J; Lynch M; Johnston PG
Clin Cancer Res; 2004 May; 10(10):3562-71. PubMed ID: 15161716
[TBL] [Abstract][Full Text] [Related]
10. Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer.
Boldrini L; Faviana P; Pistolesi F; Gisfredi S; Di Quirico D; Lucchi M; Mussi A; Angeletti CA; Baldinotti F; Fogli A; Simi P; Basolo F; Fontanini G
Oncogene; 2001 Oct; 20(45):6632-7. PubMed ID: 11641789
[TBL] [Abstract][Full Text] [Related]
11. Ceramide-induced cell death is independent of the Fas/Fas ligand pathway and is prevented by Nur77 overexpression in A20 B cells.
Brás A; Albar JP; Leonardo E; de Buitrago GG; Martínez-A C
Cell Death Differ; 2000 Mar; 7(3):262-71. PubMed ID: 10745271
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM
J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
[TBL] [Abstract][Full Text] [Related]
13. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
Sun SY; Yue P; Hong WK; Lotan R
Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific regulation of Fas/APO-1/CD95 expression by p53.
Lin P; Bush JA; Cheung KJ; Li G
Int J Oncol; 2002 Aug; 21(2):261-4. PubMed ID: 12118319
[TBL] [Abstract][Full Text] [Related]
15. Effect of C-terminal deletion of P53 on heat induced CD95 expression and apoptosis in a rat histiocytoma.
Sreedhar AS; Pardhasaradhi BV; Khar A; Srinivas UK
Oncogene; 2002 Jun; 21(25):4042-9. PubMed ID: 12037686
[TBL] [Abstract][Full Text] [Related]
16. Control of neuronal branching by the death receptor CD95 (Fas/Apo-1).
Zuliani C; Kleber S; Klussmann S; Wenger T; Kenzelmann M; Schreglmann N; Martinez A; del Rio JA; Soriano E; Vodrazka P; Kuner R; Groene HJ; Herr I; Krammer PH; Martin-Villalba A
Cell Death Differ; 2006 Jan; 13(1):31-40. PubMed ID: 16003386
[TBL] [Abstract][Full Text] [Related]
17. A novel adenoviral vector expressing human Fas/CD95/APO-1 enhances p53-mediated apoptosis.
Rakkar AN; Katayose Y; Kim M; Craig C; Ohri E; Li Z; Cowan KH; Seth P
Cell Death Differ; 1999 Apr; 6(4):326-33. PubMed ID: 10381625
[TBL] [Abstract][Full Text] [Related]
18. Isoliquiritigenin induces apoptosis and cell cycle arrest through p53-dependent pathway in Hep G2 cells.
Hsu YL; Kuo PL; Lin CC
Life Sci; 2005 Jun; 77(3):279-92. PubMed ID: 15878356
[TBL] [Abstract][Full Text] [Related]
19. Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand.
Naumann U; Kügler S; Wolburg H; Wick W; Rascher G; Schulz JB; Conseiller E; Bähr M; Weller M
Cancer Res; 2001 Aug; 61(15):5833-42. PubMed ID: 11479223
[TBL] [Abstract][Full Text] [Related]
20. Involvement of p53 and interleukin 3 in the up-regulation of CD95 (APO-1/Fas) by X-ray irradiation.
Gutiérrez del Arroyo A; Gil-Lamagniere C; Lazaro I; de Marco MC; Layunta I; Silva A
Oncogene; 2000 Jul; 19(32):3647-55. PubMed ID: 10951571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
